Editas Medicine, Inc.EDITNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank75
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P75
Within normal range
vs 2Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202524.31%
2024-60.05%
202324.56%
2022-5.64%
20218.14%
2020-299.28%
20197.18%
2018-339.71%
201778.52%
2016-681.67%